URGN FY 2015 Earnings — UroGen Pharma Ltd. Revenue & Financial Results | Market Cap Arena

URGNUroGen Pharma Ltd.

$918M

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$113,000

Operating Income

-$12M

Net Income

-$13M

EPS (Diluted)

$-5.51

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$449,000

Balance Sheet

Total Assets

$19M

Total Liabilities

$2M

Stockholders' Equity

$17M

Cash & Equivalents

$18M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$113,000	$0	—
Operating Income	-$12M	-$4M	-184.0%
Net Income	-$13M	-$5M	-178.5%